These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 2602460)

  • 1. Central versus peripheral effects on temperature preference and body temperature following alteration of 5-HT in maturing mice.
    Goodrich C; Lechner R; Slone W
    Physiol Behav; 1989 Aug; 46(2):203-9. PubMed ID: 2602460
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Central and peripheral mechanisms contribute to the antiemetic actions of delta-9-tetrahydrocannabinol against 5-hydroxytryptophan-induced emesis.
    Darmani NA; Johnson JC
    Eur J Pharmacol; 2004 Mar; 488(1-3):201-12. PubMed ID: 15044052
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of some serotoninergic agents on the rectal temperature of the domestic fowl (Gallus domesticus).
    Osuide G; Wambebe C; Bodhankar S
    Neuropharmacology; 1984 Dec; 23(12A):1407-14. PubMed ID: 6241299
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tolerance to the increased locomotor activity produced by L-5-hydroxytryptophan following peripheral decarboxylase inhibition in mice.
    Magyar RL; Gillin JC; Wyatt RJ
    Psychopharmacology (Berl); 1978 Apr; 56(3):343-50. PubMed ID: 418444
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of serotonin and L-5-hydroxytryptophan on plasma renin activity in rats.
    Barney CC; Threatte RM; Kikta DC; Fregly MJ
    Pharmacol Biochem Behav; 1981 Jun; 14(6):895-900. PubMed ID: 7019933
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The serotonin precursor 5-hydroxytryptophan elevates serum leptin levels in mice.
    Yamada J; Sugimoto Y; Ujikawa M
    Eur J Pharmacol; 1999 Oct; 383(1):49-51. PubMed ID: 10556680
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The head-twitch response to intraperitoneal injection of 5-hydroxytryptophan in the rat: antagonist effects of purported 5-hydroxytryptamine antagonists and of pirenperone, an LSD antagonist.
    Colpaert FC; Janssen PA
    Neuropharmacology; 1983 Aug; 22(8):993-1000. PubMed ID: 6604885
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum leptin levels after central and systemic injection of a serotonin precursor, 5-hydroxytryptophan, in mice.
    Yamada J; Ujikawa M; Sugimoto Y
    Eur J Pharmacol; 2000 Oct; 406(1):159-62. PubMed ID: 11011048
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence that the accumulation of 5-hydroxytryptamine in the liver but not in the brain may cause the hypoglycaemia induced by 5-hydroxytryptophan.
    Endo Y
    Br J Pharmacol; 1985 Jul; 85(3):591-8. PubMed ID: 3875380
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Central 5-HTP decarboxylase inhibiting properties of Ro 4-4602 in relation to 5-HTP potentiation in mice.
    Hyttel J; Fjalland B
    Eur J Pharmacol; 1972 Jul; 19(1):112-4. PubMed ID: 4538041
    [No Abstract]   [Full Text] [Related]  

  • 11. A behavioural and biochemical study in mice and rats of putative selective agonists and antagonists for 5-HT1 and 5-HT2 receptors.
    Goodwin GM; Green AR
    Br J Pharmacol; 1985 Mar; 84(3):743-53. PubMed ID: 2580582
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of 5-hydroxytryptamine-mediated behaviour by the putative 5-HT2 antagonist pirenperone.
    Green AR; O'Shaughnessy K; Hammond M; Schächter M; Grahame-Smith DG
    Neuropharmacology; 1983 May; 22(5):573-8. PubMed ID: 6603593
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An unexpected effect of L-5 hydroxytryptophan-ethyl-ester combined with a peripheral decarboxylase inhibitor on human serum prolactin.
    van Praag HM; Korf J; Lequin RM
    Psychopharmacol Commun; 1976; 2(5-6):369-78. PubMed ID: 1088302
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Central and peripheral components of the inhibitory actions of 5-HTP on ethanol consumption in the rat.
    Zabik JE; Sprague JE; Binkerd K
    Pharmacol Biochem Behav; 1994 Mar; 47(3):547-51. PubMed ID: 8208773
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of tolerance to the wet-dog shake behaviour but not the increase in seizure threshold induced by L-5-hydroxytryptophan during continued treatment in rats.
    Pagliusi SR; Löscher W
    Psychopharmacology (Berl); 1985; 86(1-2):118-24. PubMed ID: 2410943
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of serotonergic activation by 5-hydroxytryptophan on sleep and body temperature of C57BL/6J and interleukin-6-deficient mice are dose and time related.
    Morrow JD; Vikraman S; Imeri L; Opp MR
    Sleep; 2008 Jan; 31(1):21-33. PubMed ID: 18220075
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of peripheral mechanisms in the behavioral effects of 5-hydroxytryptophan.
    Carter RB; Dykstra LA; Leander JD; Appel JB
    Pharmacol Biochem Behav; 1978 Aug; 9(2):249-53. PubMed ID: 309609
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The influence of serotonergic agents on the body temperature.
    Pawlowski L
    Pol J Pharmacol Pharm; 1976; 28(6):615-23. PubMed ID: 138132
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of some decarboxylase inhibitors on striatal tyramines in the mouse.
    Juorio AV
    Neuropharmacology; 1983 Jan; 22(1):71-3. PubMed ID: 6843786
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [(11)C]5-HTP and microPET are not suitable for pharmacodynamic studies in the rodent brain.
    Visser AK; Ramakrishnan NK; Willemsen AT; Di Gialleonardo V; de Vries EF; Kema IP; Dierckx RA; van Waarde A
    J Cereb Blood Flow Metab; 2014 Jan; 34(1):118-25. PubMed ID: 24084697
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.